Cargando…

Inhibitor of DNA binding in heart development and cardiovascular diseases

Id proteins, inhibitors of DNA binding, are transcription regulators containing a highly conserved helix-loop-helix domain. During multiple stages of normal cardiogenesis, Id proteins play major roles in early development and participate in the differentiation and proliferation of cardiac progenitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wenyu, Xin, Yanguo, Hu, Jian, Sun, Yingxian, Zhao, Yinan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534900/ https://www.ncbi.nlm.nih.gov/pubmed/31126344 http://dx.doi.org/10.1186/s12964-019-0365-z

Ejemplares similares

Iroquois Homeodomain transcription factors in ventricular conduction system and arrhythmia
por: Hu, Wenyu, et al.
Publicado: (2018)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Function of Connexins in the Interaction between Glial and Vascular Cells in the Central Nervous System and Related Neurological Diseases
por: Zhao, Yinan, et al.
Publicado: (2018)

Quality of life and outcomes in heart failure patients with ejection fractions in different ranges
por: Chen, Xin, et al.
Publicado: (2019)

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta‐analysis
por: Hu, Wenyu, et al.
Publicado: (2018)

Tafamidis, a Noninvasive Therapy for Delaying Transthyretin Familial Amyloid Polyneuropathy: Systematic Review and Meta-Analysis
por: Zhao, Yinan, et al.
Publicado: (2019)

New Insights Into the Role of Mitochondria Quality Control in Ischemic Heart Disease
por: Xin, Yanguo, et al.
Publicado: (2021)

Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease
por: Hu, Wen, et al.
Publicado: (2022)

The cellular function and molecular mechanism of formaldehyde in cardiovascular disease and heart development
por: Zhang, Ying, et al.
Publicado: (2021)

Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%
por: Zhao, Mingyue, et al.
Publicado: (2019)

Associations between metabolic risk factors and body mass index, waist circumference, waist‐to‐height ratio and waist‐to‐hip ratio in a Chinese rural population
por: Guan, Xin, et al.
Publicado: (2015)

Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem Cells
por: Bao, Mei-Hua, et al.
Publicado: (2013)

The History and Development of HER2 Inhibitors
por: Xia, Xiaohui, et al.
Publicado: (2023)

Research progress of Nedd4L in cardiovascular diseases
por: Li, Mohan, et al.
Publicado: (2022)

The Role of Mitochondria in Metabolic Syndrome–Associated Cardiomyopathy
por: Li, Jiayu, et al.
Publicado: (2022)

Cardiovascular immune‐related adverse events: Evaluation, diagnosis and management
por: Liu, Yingxian, et al.
Publicado: (2020)

The Predictive Values of MMP-9, PLTs, ESR, and CRP Levels in Kawasaki Disease with Cardiovascular Injury
por: Yang, Yinan, et al.
Publicado: (2022)

Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease
por: Wen, Yinuo, et al.
Publicado: (2022)

The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches
por: Chen, Shuxian, et al.
Publicado: (2023)

The role of SIRT2 in vascular‐related and heart‐related diseases: A review
por: Wu, Boquan, et al.
Publicado: (2021)

Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease
por: Alendar, Andrej, et al.
Publicado: (2021)

Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease
por: Yin, Zeyu, et al.
Publicado: (2022)

E3 Ubiquitin ligase NEDD4 family‑regulatory network in cardiovascular disease
por: Zhang, Ying, et al.
Publicado: (2020)

Research Progress on N(6)-adenosylate Methylation RNA Modification in Heart Failure Remodeling
por: Yang, Yiqing, et al.
Publicado: (2023)

Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging
por: Quan, Yue, et al.
Publicado: (2020)

Mannan-Binding Lectin in Cardiovascular Disease
por: Pągowska-Klimek, Izabela, et al.
Publicado: (2014)

Immunometabolism at the Heart of Cardiovascular Disease
por: DeBerge, Matthew, et al.
Publicado: (2023)

Chromodomain Helicase DNA Binding Protein 1-like, a negative regulator of Forkhead box O3a, promotes the proliferation and migration of Angiotensin II-induced vascular smooth muscle cells
por: Zhang, Xueyao, et al.
Publicado: (2022)

The Emerging Role of the RBM20 and PTBP1 Ribonucleoproteins in Heart Development and Cardiovascular Diseases
por: Fochi, Stefania, et al.
Publicado: (2020)

Role of Oxidative DNA Damage and Repair in Atrial Fibrillation and Ischemic Heart Disease
por: Hu, Liangyu, et al.
Publicado: (2021)

Tobacco Use and Cardiovascular Disease among American Indians: The Strong Heart Study
por: Eichner, June E., et al.
Publicado: (2010)

Dirty Jobs: Macrophages at the Heart of Cardiovascular Disease
por: Stevens, Travis W., et al.
Publicado: (2022)

The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure
por: Ji, Peng‐juan, et al.
Publicado: (2023)

EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Cardiovascular MRI and CT in congenital heart disease
por: Pushparajah, Kuberan, et al.
Publicado: (2019)

Heart Failure: Advanced Development in Genetics and Epigenetics
por: Yang, Jian, et al.
Publicado: (2015)

DNA Methylation and the Potential Role of Methyl-Containing Nutrients in Cardiovascular Diseases
por: Liu, Gang, et al.
Publicado: (2017)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
por: Mezzaroma, Eleonora, et al.
Publicado: (2021)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases
por: Szczepanska-Sadowska, Ewa
Publicado: (2022)

Validating the Paradigm That Biomechanical Forces Regulate Embryonic Cardiovascular Morphogenesis and Are Fundamental in the Etiology of Congenital Heart Disease
por: Keller, Bradley B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_btmaelcjouqrqjqa1nl0h7tson